Pentagon to proceed with controversial testosterone testing after pause

Account subscription benefits alongside Premium Stories, Editorials, Opinions and more. Unlock these with Subscription

The Pentagon is reinstituting a ‌mandatory testing program for testosterone deficiency among U.S. service members aged 30 and older, a spokesperson ‌said ⁠on Thursday (September 17, 2026), bringing back a ⁠program that many medical experts have described as unnecessary and potentially harmful.

U.S. Defence Secretary Pete Hegseth, ​who has promoted ‌the use of testosterone to improve military readiness, first announced the screening mandate in July.

Under the announced guidance, ‌women were also set to ​be screened through a questionnaire and could then move to treatment ⁠for conditions related to hormonal imbalances.

In early September, however, the Pentagon temporarily rescinded ‌the published medical guidance for the testosterone screening “to allow for updates.”

The latest move lifts that pause, allowing testing to go forward. It was not immediately clear what, if any, ‌updates had been made to the original ​policy.

“Effective immediately, this guidance addresses male testosterone deficiency, establishing uniform screening ⁠and treatment pathways,” Pentagon spokesperson Sean Parnell ⁠said in a statement.

Medical professionals have warned that testosterone, if prescribed inappropriately, ‌could increase service members’ risk of infertility or lead to other ​health consequences.

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.